Clinical Trial

Pain Predict Genetics

Study acronym: PPG
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Pain is the most frequent cause of suffering and disability in society. Despite considerable involvement of genetic factors in pain sensation and sensitivity, the individual genes involved remain largely unidentified. In this project the investigators will follow patients undergoing elective major surgery for the development of acute and chronic pain. The investigators will search for clinical as well as genetic factors that can predict the development of pain. These can serve as biomarkers to predict acute and chronic pain development and progression in individual patients and help early individual treatment adaptation.
Protocol Amendment History 2 changes
critical Enrollment closed, study ongoing 2026-08-13
notable Primary completion pushed: 2027-03 -> 2028-03 2026-08-13
Trial Details
NCT Number NCT02383342
Lead Sponsor Radboud University Medical Center
Conditions Chronic Pain, Acute Pain
Enrollment 10,000 participants
Start Date 2015-05-12
Primary Completion 2028-03 (estimated)
Study Completion 2029-03 (estimated)
Updated on ClinicalTrials.gov 2026-08-12